Choosing to see a rheumatologist privately does not necessarily mean moving all future care into the private sector.
Many self-pay patients are looking for something much more focused. They may have persistent symptoms but still lack a clear diagnosis, an established rheumatological condition that is not well controlled, or a treatment plan that has stalled because of delays, uncertainty or difficulty accessing the next stage of care. Others have already been assessed several times, sometimes both within the NHS and privately, yet still feel that nobody has brought the whole picture together.
In these situations, a private rheumatology consultation can sometimes be used as a discrete piece of specialist input: reviewing what has already happened, clarifying the likely diagnosis, assessing whether treatment is working, deciding which investigations are genuinely useful and setting out a practical plan for what should happen next.
For some people, a single consultation is enough. Others may benefit from a short period of private care while treatment is adjusted or a diagnosis is clarified, while some choose to remain under private care longer term. Private rheumatology does not have to be an all-or-nothing decision.
The examples below are based on the types of patients seen in clinical practice and have been anonymised.
Why people seek a private rheumatology opinion
The reasons for seeking a private consultation vary considerably.
Some patients have ongoing joint swelling, stiffness or pain but have not yet reached a satisfactory diagnosis. Others have abnormal blood tests such as a raised CRP, rheumatoid factor or ANA and are unsure what those results mean. A different group already have conditions such as rheumatoid arthritis, gout, axial spondyloarthritis, polymyalgia rheumatica or giant cell arteritis, but their symptoms remain active despite treatment.
There are also patients with more complicated histories who have accumulated numerous blood tests, scans and clinic letters over several years. In such cases, the difficulty may not be a lack of investigation at all. The problem may be that the information has never been brought together into a coherent explanation of what is likely to be happening and what should be done next.
That distinction is important because the value of a specialist consultation should not be measured by how many new tests it generates. Sometimes the most useful intervention is careful interpretation of information that already exists.
Private care does not necessarily mean repeating everything privately
A common concern among self-pay patients is that booking one private appointment will lead automatically to a long series of privately funded blood tests, scans and follow-up consultations.
That need not be the case.
Previous NHS and private clinic letters, blood results, imaging reports and medication histories can usually provide a considerable amount of useful information. Reviewing these properly may avoid unnecessary duplication and help identify the relatively small number of unanswered questions that genuinely matter.
In some cases, no additional testing is required before a useful opinion can be given. In others, one carefully chosen investigation may be more valuable than a broad panel of tests ordered without a specific clinical question.
This is particularly relevant for self-pay patients because private investigations can become expensive very quickly. A detailed set of blood tests can cost £250 or more, while specialist MRI imaging may exceed £1,000 depending on the area being scanned and the protocol required.
There are occasions when paying privately for a test is worthwhile, especially when the result is needed quickly and is likely to change immediate treatment. There are also many situations where it is reasonable to take a recommendation back into NHS care and allow the NHS team to decide whether and how it should be pursued within its own pathway.
The important principle is that investigations should be driven by clinical value rather than by the fact that they are available privately.
When the main problem is reaching a diagnosis
Rheumatological diagnoses are not always straightforward. Joint pain and swelling can arise from inflammatory arthritis, gout, osteoarthritis, tendon problems, hypermobility and many other conditions. Raised inflammatory markers have numerous possible causes, while autoantibodies such as ANA and rheumatoid factor can sometimes confuse matters when they are interpreted without reference to symptoms and examination findings.
A specialist consultation can therefore add value even when it does not lead immediately to another scan or blood test. Sometimes the most important step is deciding which diagnosis best explains the pattern and whether the investigations already performed have answered more of the question than was initially appreciated.
One self-pay patient had persistent wrist swelling and pain severe enough to interfere with work. The problem had been ongoing despite previous medical assessment, yet there was still no satisfactory explanation for the symptoms and no effective long-term strategy.
A focused rheumatology assessment allowed the history, examination and previous investigations to be considered together, and the overall pattern was consistent with gout. Once the diagnosis was established, a treatment plan could be put in place to bring the condition under control and reduce the likelihood of further attacks.
The patient did not need to remain indefinitely within private care. Once the diagnosis and longer-term management strategy were clear, ongoing treatment could continue through the NHS.
In that situation, the value of the private appointment lay principally in reaching the correct diagnosis and establishing a workable plan rather than creating a new private healthcare pathway.
When previous NHS and private opinions have still not produced a clear answer
A different problem arises when a patient has already been assessed extensively but the overall picture remains unclear.
Some people have symptoms involving several systems, fluctuating blood-test abnormalities and imaging findings that do not fit neatly into a single diagnosis. They may already have seen several clinicians in both NHS and private settings, yet still lack a coherent explanation or management plan.
One patient had a prolonged and complicated clinical history and had already undergone assessment through both routes. Despite this, there was still no sufficiently clear diagnosis and no satisfactory strategy for what should happen next.
An extended second opinion consultation provided the time needed to reconstruct the chronology of symptoms, review previous specialist opinions, assess the investigation history and distinguish findings that were likely to be clinically important from those that were less likely to explain the overall presentation.
Bringing the information together in this way led to a clearer diagnosis and a structured management plan, including which investigations were genuinely useful, how treatment should be approached and which elements of care could subsequently be pursued through existing NHS services.
The benefit was not simply obtaining another opinion. It was having enough time and specialist input to integrate a fragmented medical history into a coherent clinical picture.
When the diagnosis is already known but disease control is poor
Not every self-pay patient is searching for a diagnosis. Some already have an established rheumatological condition but seek a private opinion because the disease has become more active, treatment is no longer working adequately or they are waiting for the next stage of NHS care.
In these circumstances, private treatment can sometimes act as a bridge rather than a permanent alternative to NHS management.
One patient with established rheumatoid arthritis developed a significant flare while already under NHS care. The immediate problem was not diagnostic uncertainty but active inflammatory disease that was affecting everyday function while the longer-term treatment pathway was being considered.
A private review allowed current disease activity and existing treatment to be reassessed, with short-term treatment arranged to bring the flare under better control. The clinic letter also documented the extent of active disease and explained why escalation to biologic treatment should be considered.
That specialist opinion could then be reviewed by the NHS rheumatology team, and the patient was subsequently able to access biologic medication through the NHS once the relevant screening tests and funding application had been undertaken.
The private consultation therefore addressed the immediate problem and helped clarify the rationale for longer-term treatment without requiring the patient to fund biologic therapy indefinitely.
Using private treatment as a temporary bridge
A similar principle can apply when the diagnosis is already established but access to treatment is delayed.
One patient had been diagnosed with axial spondyloarthritis but continued to experience substantial inflammatory symptoms while waiting to progress through the NHS treatment pathway. Her disease had become sufficiently active that she was no longer able to work.
After discussion of the options, she chose to fund biologic treatment privately rather than wait for treatment to become available through the NHS.
The intention was not to establish a permanent private pathway. The immediate aim was to control active inflammatory disease at a time when the consequences of waiting were already significant.
Treatment improved disease control and allowed her to return to work. Once the initial period of private treatment had been completed, ongoing management could transfer to the NHS, subject to the NHS team confirming the diagnosis, indication and local prescribing requirements.
For that patient, privately funded treatment acted as a bridge between diagnosis and longer-term NHS care.
Private and NHS care can sometimes work sequentially
These examples illustrate why private and NHS rheumatology should not always be viewed as completely separate or competing systems.
A patient may use a private consultation to establish a diagnosis and then continue treatment through the NHS. Another may need short-term private management of a flare while remaining fundamentally under NHS care. Someone else may choose to fund treatment privately for a limited period because the functional consequences of waiting have become substantial, before transferring back into NHS management.
The precise route depends on the condition, how urgent the clinical problem is, what is available through existing NHS pathways and what the individual patient feels comfortable funding.
This flexibility is particularly important for self-pay patients, who may be willing to pay for specialist expertise at a particular point in their care without wishing, or being able, to fund every subsequent investigation and treatment privately.
Sometimes the right private advice is not to do more
There is an understandable assumption that paying privately should result in more tests, faster scans or additional treatment.
That is not necessarily good medicine.
Patients sometimes attend having already undergone extensive investigation and ask whether they should pay for another MRI, a broader autoimmune panel, repeated blood tests or further specialist imaging because symptoms have persisted.
There are circumstances where those investigations are appropriate. There are also situations where they are unlikely to change the diagnosis or management.
One patient, for example, had already undergone substantial imaging but remained concerned that something had been missed and was considering paying privately for further MRI scans. Review of the symptoms, examination findings and previous imaging suggested that repeating the scans was unlikely to provide useful additional information.
The more appropriate approach was to explain what had already been excluded, identify the most likely explanation for the ongoing symptoms and develop a treatment and follow-up plan based on the evidence that was already available.
For that patient, the useful outcome of the private consultation was not another investigation. It was greater clarity and the avoidance of unnecessary expenditure.
The same principle applies to blood testing. A mildly positive ANA or rheumatoid factor may sometimes prompt requests for increasingly broad autoimmune panels when the history and examination do not suggest an inflammatory disease. In the right clinical context, the most useful advice may be that further rheumatological testing is unlikely to help.
Good private care is therefore not about doing more simply because more can be done. It is about identifying what is likely to change the patient's care and being equally willing to advise against investigations that are unlikely to add value.
When continuing private care is the preferred option
Not every patient wants to return to NHS care once a diagnosis has been established.
One patient was diagnosed with polymyalgia rheumatica and giant cell arteritis and decided to continue as a self-pay private patient.
Giant cell arteritis can require prompt investigation, careful monitoring and treatment adjustments over time. In this case, the patient was comfortable funding the necessary imaging, blood tests and ongoing specialist follow-up privately.
For that individual, remaining within private care suited both the clinical situation and personal preference.
Another patient with exactly the same diagnosis might reasonably choose to transfer ongoing management into the NHS after the initial diagnosis and treatment plan had been established.
There is no single model that is right for everyone. The appropriate choice depends on clinical need, continuity, access, cost and patient preference.
The clinic letter can be as important as the consultation
When a patient intends to continue care within the NHS, the quality of the clinic letter becomes particularly important.
A useful letter should do more than reproduce a history and list blood-test results. It should explain the likely diagnosis, relevant alternatives where uncertainty remains, how previous investigations should be interpreted, which further tests are genuinely necessary and what treatment options should be considered.
That gives the patient something concrete to take back to their GP or NHS specialist and reduces the likelihood that the private appointment becomes an isolated opinion disconnected from their wider healthcare.
The NHS clinician remains responsible for deciding what can appropriately be implemented within NHS care, but a clearly reasoned specialist assessment can help make the clinical question and proposed next steps considerably clearer.
When a one-off consultation may be enough
A single consultation can be particularly useful when someone has already undergone substantial investigation but still does not understand what is causing their symptoms, when there is uncertainty about whether a rheumatological diagnosis has been missed, or when an established disease remains poorly controlled and an independent review of treatment would be helpful.
It can also be valuable when a patient needs help deciding whether proposed investigations are genuinely worthwhile.
For self-pay patients, this aspect is particularly important because avoiding an unnecessary £1,000 MRI or repeated blood panels may be as valuable as arranging an appropriate investigation quickly.
There are, however, situations where one consultation will not be sufficient. Starting or adjusting certain medications may require monitoring, an evolving diagnosis may need review over time, and some complex inflammatory conditions require ongoing specialist supervision. A responsible private assessment should be clear about this rather than creating an expectation that every problem can be resolved in a single appointment.
Making a one-off consultation as useful as possible
The more complete the information available beforehand, the more value can usually be obtained from a focused specialist review.
Previous clinic correspondence, relevant blood-test results, imaging reports and an up-to-date medication list can prevent time being spent reconstructing information that already exists. Photographs of intermittent joint swelling, rashes, ulcers or Raynaud's colour changes can also be useful when the abnormality is not present on the day of the appointment.
For more complicated histories, a brief chronology of how symptoms developed can be particularly helpful.
The aim is not to arrive with every medical document ever produced, but to provide enough relevant information for the consultation to concentrate on interpretation and decision-making.
The value lies in specialist judgement rather than the number of tests ordered
For many self-pay patients, the most useful outcome of a rheumatology consultation is relatively simple: understanding what is most likely to be wrong, what has already been excluded, what still requires investigation and what treatment strategy makes sense.
For one patient, that may mean establishing a diagnosis that has previously been missed. For another, it may mean optimising treatment during a disease flare. For someone else, it may mean beginning treatment privately for a limited period before transferring longer-term care to the NHS.
Occasionally, the most valuable advice is that another scan or another set of blood tests is unlikely to help.
This is why the quality of private care should not be judged by how much medicine is purchased or how many investigations are arranged. The value lies in making better clinical decisions and giving the patient a clearer route forward.
The key message
Paying for a private rheumatology consultation does not necessarily mean transferring all future care into the private sector.
A focused self-pay appointment can be used to clarify a diagnosis, review poorly controlled disease, interpret previous investigations, obtain an independent opinion about treatment or establish a practical plan that can subsequently be pursued through NHS care.
Private tests and treatment can be useful, but they can also be expensive. Blood testing may cost several hundred pounds and complex MRI imaging can exceed £1,000, so part of good private practice is deciding not only what can be done, but what actually needs to be done.
For some patients, one consultation and a detailed management plan are sufficient. Others use private care temporarily while a diagnosis is established or treatment is stabilised, before returning to the NHS. Some choose to continue privately because that model suits their circumstances and they are comfortable funding ongoing care.
The most useful way to think about private rheumatology is therefore not as an alternative healthcare system that has to be entered permanently, but as access to specialist expertise that can be used flexibly at the points where it adds most value.
Dr Animesh Singh, Consultant Rheumatologist. GMC: 6130215
Related Articles
What Is a Rheumatologist and When Should You See One?
Please note, these posts are for general information only and do not constitute medical advice. Dr Singh would encourage you to speak to your healthcare professional to be assessed and managed for your specific symptoms.